Health Care·Health Care Services·$5.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.57 | N/A | +20.77% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.57 | N/A | +20.77% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting operational efficiency as a priority. However, they did not provide specific guidance for the upcoming quarters.
We are pleased with our earnings performance this quarter.
Our focus remains on maintaining operational efficiency.
Chemed Corp New reported a strong EPS performance, exceeding expectations by over 20%. However, the stock fell by 0.9% in reaction to the lack of revenue data and guidance. Investors may be cautious as the company did not provide future outlooks, which could lead to uncertainty in the market.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
DIGITAL RLTY TR INC REIT
Feb 15, 2013